Four-years retention rate of golimumab administered after discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases
13/06/2023
Pombo-Suárez M, Seoane-Mato D, Díaz-González F, Sánchez-Alonso F, Sánchez-Jareño M, Cea-Calvo L, Castrejón I
https://doi.org/10.1186/s42358-023-00296-1
doi: 10.1186/s42358-023-00296-1